Immediate Impact

54 standout
Sub-graph 1 of 25

Citing Papers

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
The oral–gut microbiome axis in health and disease
2024 Standout
2 intermediate papers

Works of A. Thoelke being referenced

Clinical Phase II Study of Pegylated Liposomal Doxorubicin as Second-Line Treatment in Disseminated Melanoma
2004
The influence of maternal exposure to volatile organic compounds on the cytokine secretion profile of neonatal T cells
2002

Author Peers

Author Last Decade Papers Cites
A. Thoelke 73 107 51 61 7 289
Joseph Rastrick 86 28 81 11 7 247
Eric Kleerup 47 14 43 29 9 255
Sang A Park 116 74 131 37 12 316
Katherine C. Goldfarbmuren 73 21 60 33 8 251
Tommaso Cavalleri 90 104 107 72 11 331
Nicolas Lemonnier 59 62 8 62 6 186
C Viganò 18 88 30 21 12 237
Annette Wright 81 85 14 50 12 294
Heladio P. Ibarguen 132 111 22 11 10 300
Anna H. Wu 83 66 17 21 7 272

All Works

Loading papers...

Rankless by CCL
2026